Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patients
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Apr 2017 Status changed from recruiting to completed.
- 03 Aug 2016 Planned End Date changed from 28 Feb 2017 to 28 Apr 2017.
- 27 Jul 2016 Status changed from not yet recruiting to recruiting.